ArticleMedComm2025

Safety, Tolerability, and Pharmacokinetics of a Novel Nitroimidazooxazole Antitubercular Agent in Healthy Adults: A Phase I Trial.

Jia Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.